1. Home
  2. THAR vs SMSI Comparison

THAR vs SMSI Comparison

Compare THAR & SMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THAR
  • SMSI
  • Stock Information
  • Founded
  • THAR 2017
  • SMSI 1982
  • Country
  • THAR United States
  • SMSI United States
  • Employees
  • THAR N/A
  • SMSI N/A
  • Industry
  • THAR Biotechnology: Pharmaceutical Preparations
  • SMSI Computer Software: Prepackaged Software
  • Sector
  • THAR Health Care
  • SMSI Technology
  • Exchange
  • THAR Nasdaq
  • SMSI Nasdaq
  • Market Cap
  • THAR 16.8M
  • SMSI 15.3M
  • IPO Year
  • THAR 2022
  • SMSI 1995
  • Fundamental
  • Price
  • THAR $3.16
  • SMSI $0.81
  • Analyst Decision
  • THAR Strong Buy
  • SMSI Strong Buy
  • Analyst Count
  • THAR 1
  • SMSI 1
  • Target Price
  • THAR $17.00
  • SMSI $5.00
  • AVG Volume (30 Days)
  • THAR 556.4K
  • SMSI 614.3K
  • Earning Date
  • THAR 11-06-2025
  • SMSI 11-12-2025
  • Dividend Yield
  • THAR N/A
  • SMSI N/A
  • EPS Growth
  • THAR N/A
  • SMSI N/A
  • EPS
  • THAR N/A
  • SMSI N/A
  • Revenue
  • THAR N/A
  • SMSI $18,658,000.00
  • Revenue This Year
  • THAR N/A
  • SMSI N/A
  • Revenue Next Year
  • THAR N/A
  • SMSI $59.48
  • P/E Ratio
  • THAR N/A
  • SMSI N/A
  • Revenue Growth
  • THAR N/A
  • SMSI N/A
  • 52 Week Low
  • THAR $0.95
  • SMSI $0.60
  • 52 Week High
  • THAR $9.08
  • SMSI $1.95
  • Technical
  • Relative Strength Index (RSI)
  • THAR 51.38
  • SMSI 54.64
  • Support Level
  • THAR $2.79
  • SMSI $0.77
  • Resistance Level
  • THAR $3.52
  • SMSI $0.82
  • Average True Range (ATR)
  • THAR 0.25
  • SMSI 0.06
  • MACD
  • THAR 0.02
  • SMSI 0.00
  • Stochastic Oscillator
  • THAR 51.02
  • SMSI 48.42

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

About SMSI Smith Micro Software Inc.

Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.

Share on Social Networks: